Unit
Gastroenterology/Hepatology
GASTRO · Dept. I
Daptomycin for highly resistant Enterococcus faecium infection
Rosin C, Bernsmeier C, Entenza J, Moreillon P, Frei R, Maja W, Fluckiger U. Daptomycin for highly resistant Enterococcus faecium infection. Swiss Med Wkly 2012; 142:w13603.
Jun 26, 2012Daptomycin for highly resistant Enterococcus faecium infection
Jun 26, 2012Swiss Med Wkly 2012; 142:w13603
Rosin Christiane, Bernsmeier Christine, Entenza José M, Moreillon Philippe, Frei Reno, Maja Weisser, Fluckiger Ursula
Atemberaubendes Zweihöhlenproblem
Müller F, Binek J, Diethelm M. Atemberaubendes Zweihöhlenproblem. Swiss Medcial Forum 2012; 12:494-495.
Jun 16, 2012Atemberaubendes Zweihöhlenproblem
Jun 16, 2012Swiss Medcial Forum 2012; 12:494-495
Müller Franziska, Binek Janek, Diethelm Markus
[Hepatitis C! Experience in diagnosis and medical treatment. A literature review]
Künzler-Heule P, Panfil E. [Hepatitis C! Experience in diagnosis and medical treatment. A literature review]. Pflege 2012; 25:185-95.
Jun 1, 2012[Hepatitis C! Experience in diagnosis and medical treatment. A literature review]
Jun 1, 2012Pflege 2012; 25:185-95
Künzler-Heule Patrizia, Panfil E
Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms
Zitzmann K, Vlotides G, Brand S, Lahm H, Spöttl G, Göke B, Auernhammer C. Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms. Endocr Relat Cancer 2012; 19:423-34.
May 24, 2012Perifosine-mediated Akt inhibition in neuroendocrine tumor cells: role of specific Akt isoforms
May 24, 2012Endocr Relat Cancer 2012; 19:423-34
Zitzmann Kathrin, Vlotides George, Brand Stephan, Lahm Harald, Spöttl Gerald, Göke Burkhard, Auernhammer Christoph J
Analysis of IL12B gene variants in inflammatory bowel disease
Glas J, Czamara D, Diegelmann J, Ochsenkühn T, Göke B, Wetzke M, Steib C, Stallhofer J, Beigel F, Friedrich M, Tillack C, Fries C, Olszak T, Wagner J, Seiderer J, Brand S. Analysis of IL12B gene variants in inflammatory bowel disease. PloS one 2012; 7:e34349.
Mar 30, 2012Analysis of IL12B gene variants in inflammatory bowel disease
Mar 30, 2012PloS one 2012; 7:e34349
Glas Jürgen, Czamara Darina, Diegelmann Julia, Ochsenkühn Thomas, Göke Burkhard, Wetzke Martin, Steib Christian, Stallhofer Johannes, Beigel Florian, Friedrich Matthias, Tillack Cornelia, Fries Christoph, Olszak Torsten, Wagner Johanna, Seiderer Julia, Brand Stephan
PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background
Glas J, Czamara D, Diegelmann J, Karbalai N, Ochsenkühn T, Göke B, Steib C, Friedrich M, Stallhofer J, Tillack C, Beigel F, Wetzke M, Olszak T, Seiderer J, Wagner J, Brand S. PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background. PloS one 2012; 7:e33682.
Mar 21, 2012PTPN2 gene variants are associated with susceptibility to both Crohn's disease and ulcerative colitis supporting a common genetic disease background
Mar 21, 2012PloS one 2012; 7:e33682
Glas Jürgen, Czamara Darina, Diegelmann Julia, Karbalai Nazanin, Ochsenkühn Thomas, Göke Burkhard, Steib Christian, Friedrich Matthias, Stallhofer Johannes, Tillack Cornelia, Beigel Florian, Wetzke Martin, Olszak Torsten, Seiderer Julia, Wagner Johanna, Brand Stephan
Epidemiologie und Ätiologie des hepatozellulären Karzinoms
Sawatzki M, Semela D. Epidemiologie und Ätiologie des hepatozellulären Karzinoms. Tumordiagnostik und Therapie 2012; 1:10-13.
Feb 17, 2012Epidemiologie und Ätiologie des hepatozellulären Karzinoms
Feb 17, 2012Tumordiagnostik und Therapie 2012; 1:10-13
Sawatzki Mikael, Semela David
Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study
Häuptle R, Weilenmann D, Schneider T, Haile S, Ammann P, Knellwolf C, Borovicka J. Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study. Wien Med Wochenschr 2012; 162:67-73.
Feb 1, 2012Individualised PPI prescription in patients on combination antiplatelet therapy and upper gastrointestinal events after percutaneous coronary intervention: a cohort study
Feb 1, 2012Wien Med Wochenschr 2012; 162:67-73
Häuptle Rahel, Weilenmann Daniel, Schneider Tino, Haile Sarah, Ammann Peter, Knellwolf Christina, Borovicka Jan
Disruption of Notch1 induces vascular remodeling, intussusceptive angiogenesis, and angiosarcomas in livers of mice
Dill M, Heim M, Radtke F, Meili-Butz S, Terracciano L, Tornillo L, Hlushchuk R, Djonov V, Rothweiler S, Semela D. Disruption of Notch1 induces vascular remodeling, intussusceptive angiogenesis, and angiosarcomas in livers of mice. Gastroenterology 2012; 142:967-977.e2.
Jan 12, 2012Disruption of Notch1 induces vascular remodeling, intussusceptive angiogenesis, and angiosarcomas in livers of mice
Jan 12, 2012Gastroenterology 2012; 142:967-977.e2
Dill Michael T, Heim Markus H, Radtke Freddy, Meili-Butz Silvia, Terracciano Luigi, Tornillo Luigi, Hlushchuk Ruslan, Djonov Valentin, Rothweiler Sonja, Semela David
Quality assurance of sphincterotomy: A prospective single-center survey
Sulz M, Sagmeister M, Schelling M, Binek J, Borovicka J, Ulmer H, Meyenberger C. Quality assurance of sphincterotomy: A prospective single-center survey. Central European Journal of European Medicine 2012; 7:9-19.
Jan 1, 2012Quality assurance of sphincterotomy: A prospective single-center survey
Jan 1, 2012Central European Journal of European Medicine 2012; 7:9-19
Sulz Michael, Sagmeister Markus, Schelling Martin, Binek Janek, Borovicka Jan, Ulmer Hanno, Meyenberger Christa
Eine nicht-alltägliche Ursache der Eisenmangel-Anämie
Regli M, Meyenberger C, Markert E, Sawatzki M. Eine nicht-alltägliche Ursache der Eisenmangel-Anämie. Praxis 2012; 101:735-738.
Jan 1, 2012Eine nicht-alltägliche Ursache der Eisenmangel-Anämie
Jan 1, 2012Praxis 2012; 101:735-738
Regli Mattias, Meyenberger Christa, Markert E., Sawatzki Mikael
Autoimmunhepatitis
Sulz M, Gerlach T. Autoimmunhepatitis. Therapeutische Umschau 2011; 68:189-194.
Dec 29, 2011Autoimmunhepatitis
Dec 29, 2011Therapeutische Umschau 2011; 68:189-194
Sulz Michael, Gerlach Tilman Jörn
The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease
Glas J, Czamara D, Diegelmann J, Friedrich M, Steib C, Beigel F, Olszak T, Tillack C, Fries C, Wetzke M, Bayrle C, Seiderer J, Brand S. The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease. PloS one 2011; 6:e29309.
Dec 29, 2011The role of osteopontin (OPN/SPP1) haplotypes in the susceptibility to Crohn's disease
Dec 29, 2011PloS one 2011; 6:e29309
Glas Jürgen, Czamara Darina, Diegelmann Julia, Friedrich Matthias, Steib Christian, Beigel Florian, Olszak Torsten, Tillack Cornelia, Fries Christoph, Wetzke Martin, Bayrle Corinna, Seiderer Julia, Brand Stephan
Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease
Beigel F, Ochsenkühn T, Seiderer J, Göke B, Weidinger M, Breiteneicher S, Schnitzler F, Tillack C, Laubender R, Löhr B, Brand S. Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease. Digestion 2011; 85:47-54.
Dec 14, 2011Iron status and analysis of efficacy and safety of ferric carboxymaltose treatment in patients with inflammatory bowel disease
Dec 14, 2011Digestion 2011; 85:47-54
Beigel Florian, Ochsenkühn Thomas, Seiderer Julia, Göke Burkhard, Weidinger Maria, Breiteneicher Simone, Schnitzler Fabian, Tillack Cornelia, Laubender Rüdiger P, Löhr Beate, Brand Stephan
Endoscopic treatment of paraesophageal abscess in eosinophilic esophagitis after chest trauma
Sawatzki M, Stienen M, Straumann A, Meyenberger C, Öhlschlegel C, Binek J. Endoscopic treatment of paraesophageal abscess in eosinophilic esophagitis after chest trauma. Gastrointest Endosc 2011
Dec 7, 2011Endoscopic treatment of paraesophageal abscess in eosinophilic esophagitis after chest trauma
Dec 7, 2011Gastrointest Endosc 2011
Sawatzki Mikael, Stienen Martin N., Straumann Alex, Meyenberger Christa, Öhlschlegel Christian, Binek Janek
A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins
Diegelmann J, Olszak T, Göke B, Blumberg R, Brand S. A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins. J Biol Chem 2011; 287:286-98.
Nov 8, 2011A novel role for interleukin-27 (IL-27) as mediator of intestinal epithelial barrier protection mediated via differential signal transducer and activator of transcription (STAT) protein signaling and induction of antibacterial and anti-inflammatory proteins
Nov 8, 2011J Biol Chem 2011; 287:286-98
Diegelmann Julia, Olszak Torsten, Göke Burkhard, Blumberg Richard S, Brand Stephan
Homozygosity for the NOD2 p.Leu1007fsX1008 variant is the main genetic predictor for fibrostenotic Crohn's disease
Brand S. Homozygosity for the NOD2 p.Leu1007fsX1008 variant is the main genetic predictor for fibrostenotic Crohn's disease. Inflamm Bowel Dis 2011; 18:393-4.
Oct 29, 2011Homozygosity for the NOD2 p.Leu1007fsX1008 variant is the main genetic predictor for fibrostenotic Crohn's disease
Oct 29, 2011Inflamm Bowel Dis 2011; 18:393-4
Brand Stephan
Dominant disease-causing effect of NOD2 mutations in a family with all family members affected by Crohn's disease
Schnitzler F, Seiderer J, Stallhofer J, Brand S. Dominant disease-causing effect of NOD2 mutations in a family with all family members affected by Crohn's disease. Inflamm Bowel Dis 2011; 18:395-6.
Oct 12, 2011Dominant disease-causing effect of NOD2 mutations in a family with all family members affected by Crohn's disease
Oct 12, 2011Inflamm Bowel Dis 2011; 18:395-6
Schnitzler Fabian, Seiderer Julia, Stallhofer Johannes, Brand Stephan
Malignant melanoma during ustekinumab therapy of Crohn's disease
Ehmann L, Tillack-Schreiber C, Brand S, Wollenberg A. Malignant melanoma during ustekinumab therapy of Crohn's disease. Inflamm Bowel Dis 2011; 18:E199-200.
Oct 10, 2011Malignant melanoma during ustekinumab therapy of Crohn's disease
Oct 10, 2011Inflamm Bowel Dis 2011; 18:E199-200
Ehmann Laura M, Tillack-Schreiber Cornelia, Brand Stephan, Wollenberg Andreas
Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery
Kasparek M, Bruckmeier A, Beigel F, Müller M, Brand S, Mansmann U, Jauch K, Ochsenkühn T, Kreis M. Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery. Inflamm Bowel Dis 2011; 18:1207-13.
Sep 16, 2011Infliximab does not affect postoperative complication rates in Crohn's patients undergoing abdominal surgery
Sep 16, 2011Inflamm Bowel Dis 2011; 18:1207-13
Kasparek Michael S, Bruckmeier Andreas, Beigel Florian, Müller Mario H, Brand Stephan, Mansmann Ulrich, Jauch Karl-Walter, Ochsenkühn Thomas, Kreis Martin E